Call for Abstracts

Abstract submission opens:  January 16 (Tue), 2018
Abstract submission deadline:  February 23 (Fri), 2018
Please note that all the applicants are requested to complete the payment of registration fee before the Congress and obtain a visa for entering Japan prior to the Congress if necessary.

Type of Presentation

  • Oral/Poster Presentation
  • Investigators' Award
    An applicant must:
    • be under the age of 35 as of March 31, 2018,
    • be a presenter of poster presentation (Award applicants are to do an oral presentation too),
    • be pre-registered for the Congress and complete the payment of registration fee before the Congress,
    • obtain a visa for entering Japan prior to the Congress, if necessary.

    The names of award winner will be announced on July 19 (Thu), 2018. The ceremony will take place at the annual meeting site on July 20 (Fri), 2018. The award winners will receive a certificate and a grant.

Conflicts of Interest (COI)

Please note that all speakers are required to make the disclosure regardless whether or not there is a state of conflict of interest (COI).

[Disclosure method]
For oral session, include a self-disclosure of the state of COI in the second slide (following the title slide). For poster session, disclose the state of COI after the conclusion or the acknowledgement.

Sample slides are available here.


Ethical Consideration

All human and animal studies must have been approved by the authors' institutional review board. All clinical investigation must have been conducted according to Declaration of Helsinki principles. Keep subjects' personal information confidential.

Submission Procedures

The presenting authors MUST submit abstract by themselves who have the membership.
Click the "Go to Abstract Submission page" button on this page. We recommend you to register early, for the online submission system is likely to be heavily accessed as the deadline approaches.
Applicants registering for the first time are requested to make a new account entering their personal information first.
Read and follow the instruction on the screens, and fill in the required fields. The items you are required to fill in are as follows:

  • Presenting author's personal information
  • Name of authors (no more than 20 authors), affiliated institutions (no more than 15 institutions)
  • Type of presentation (Oral/Poster/Either)
  • Application for Investigators' Award (ONLY for poster presenters)
  • Title of presentation (should be under 200 characters)
  • Abstract body
    - It should be below 1600 characters (include spaces).
    - Do not include the title, names and institutions of authors.
    - It should NOT contain figure or table.
    - It must contain a brief, clear statement of conclusion.
    - Please make it by MS Word file (.doc OR .docx) and submit it through the online system.
  • Category
    *Please select ONE.
    101 Pharmaceutical drugs (chemicals) 304 Carcinogenicity
    102 Biopharmaceuticals and nucleic-acid medicines 305 Behavioral toxicology
    103 Regenerative medicine and cell therapy 306 Immunotoxicology
    104 Agricultural chemicals 307 Drug dependency
    105 Metals 308 Cytotoxicity
    106 Industrial chemicals 401 Oxidative stress
    107 Toxins 402 Inflammation
    108 Foods, food additives, and food contaminants 403 Mechanisms of toxicity
    109 Environmental pollutants 404 Cellular response
    110 Endocrine disruptors 405 Molecular toxicology
    111 Nanomaterials 406 Gene regulation
    112 Radiation 407 Genetic polymorphism
    113 Other materials 408 Epigenetics
    201 Nervous system 409 Omics
    202 Liver 410 Biomarkers
    203 Kidney 411 Toxicity-testing methods
    204 Skin 412 Analytical method
    205 Sensory organ 413 Toxicokinetics
    206 Gastrointestinal system 414 Toxicologic pathology
    207 Respiratory system 415 Statistics
    208 Cardio vascular system 416 Alternatives to mammalian models
    209 Reproductive system 417 Animal model
    210 Endocrine system 418 Epidemiology
    211 Other organs or system 419 Clinical toxicology
    301 General toxicology 420 Hypersensitive subjects
    302 Reproductive and developmental toxicology 421 Risk assessment and communication
    303 Genetic toxicology 422 Information technology, AI, and big data
After finishing abstract submission, you will receive "notification message" to your registered e-mail address (ID) for confirmation. If you do not receive such an e-mail within 24 hours, please contact the Congress Management Office.

Modify and update your abstract

You can change/modify your abstract until the deadline of abstract submission by logging in to the Abstract Submission page.
After the deadline of the abstract submission, no modifications, changes, or additions whatsoever to the abstract body, authors (either first author or co-authors), or affiliations are permitted.
Please take great care to ensure that no mistakes are made before your submission.

Personal Information Protection

Registered personal information use only for the 45th annual meeting.
The information is protected and securely saved with necessary security.
This Meeting (JSOT45) agrees to WHO and IUTOX's Tobacco Control Act.
Presenting authors MUST submit their abstracts by themselves.

Notification of acceptance

The final decision to accept or reject the submitted abstracts will be made by the Organizing Committee. A notification of acceptance or rejection will be sent by e-mail in April 2018 (tentative).

Information about VISA

Please check the "Guide to Japanese VISA" through the URL below.
Ministry of Foreign Affairs of Japan (
Please fill in the necessary documents for your VISA application and send by e-mail to the Congress Management Office. We will complete the documents and send back to you by mail.

For inquiries

Congress Management Office